Antimicrobianos

Membrane-disrupting agent

This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Cefsulodin sodium salt is a beta lactam antibiotic in the third-generation cephalosporin family that inhibits penicillin-binding proteins (PBPs) to disrupt bacterial cell wall synthesis.

Carbomycin is a macrolide antibiotic, which is derived from the bacterium Streptomyces halstedii. This antibiotic functions by binding to the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. Through this mechanism, carbomycin effectively disrupts the growth and replication of susceptible bacterial strains, making it a potent tool in combating bacterial infections.

Gatifloxacin is an antibiotic, which is a synthetic fluoroquinolone with broad-spectrum antibacterial activity. Its source lies in its chemical synthesis, designed to inhibit bacterial enzymes necessary for DNA replication. The mode of action involves the inhibition of bacterial DNA gyrase and topoisomerase IV, which are critical enzymes for bacterial DNA replication, transcription, and repair. This dual inhibitory mechanism disrupts bacterial cell division and growth, leading to the eventual eradication of susceptible bacterial strains.

Inhibitor of cell-wall synthesis; carbapenem class

Inhibitor of beta-lactamase; inhibitor of cell wall synthesis; beta-lactam class

Fostriecin is a potent anticancer agent, which is a natural product isolated from the bacterium Streptomyces pulveraceus. It acts primarily as an inhibitor of protein phosphatases, particularly protein phosphatase 2A (PP2A) and protein phosphatase 4 (PP4), functioning by blocking their catalytic activity. This inhibition disrupts cell cycle regulation, leading to apoptosis in cancer cells.

GSK 2838232 is a HIV-1 maturation inhibitor with action on HIV-1 Gag protein cleavage and is used for research on HIV treatment.

Emtricitabine is an antiviral drug that is used to treat chronic viral hepatitis, which is caused by the hepatitis B and C viruses. The drug blocks the activity of reverse transcriptase, which is an enzyme necessary for the replication of viral RNA in the body. Emtricitabine has been shown to be effective against acute hepatitis B virus infection and chronic hepatitis B virus infection with or without cirrhosis. It also has been shown to be effective against chronic hepatitis C virus infection with or without cirrhosis.

Potassium clavulanate is a beta-lactamase inhibitor and an antibacterial agent. The presence of potassium clavulanate in culture media inhibits the activity of beta-lactamases, which are enzymes that confer resistance to penicillin and other beta-lactam antibiotics. It also has been shown to be active against bacterial infections such as tuberculosis, sepsis, and pneumonia, where it can inhibit the growth of bacteria by interfering with their ability to form cell walls. Potassium clavulanate is also used as an antimicrobial agent for blood culture technique and antimicrobial treatment.

Inhibitor of bacterial cell wall biogenesis; penicillin class

Amicoumacin A is an antibiotic compound, which is derived from the bacterium Bacillus subtilis. This natural source is known for its production of a variety of biologically active compounds that contribute to its utility in numerous scientific contexts. The mode of action of Amicoumacin A involves the inhibition of bacterial protein synthesis by targeting the ribosomal subunit. Specifically, it interferes with the translation process, effectively disrupting the growth and proliferation of susceptible bacterial strains.

Amicoumacin A is primarily utilized in research settings to study bacterial resistance mechanisms, as well as to explore novel antibacterial therapies. Its application in scientific research extends to examining its potential synergistic effects with other antimicrobial agents, and it serves as a model compound for understanding ribosomal inhibition. The study of Amicoumacin A not only contributes to the broader field of antibiotic development but also offers insights into the molecular interactions that underlie bacterial protein synthesis and antibiotic resistance. This compound's unique properties make it an important subject of investigation for microbiologists and pharmacologists alike, emphasizing its relevance in the ongoing battle against antibiotic-resistant pathogens.

Triazavirin is an antiviral drug developed against SAR-CoV-2. The action of triazavirin might be due to its ability to inhibit the Mpro protease from SARS viruses. Triazavirin has been clinically tested in the treatment of COVID-19 patients.

D-Cycloserine is a antibiotic and NMDA receptor partial agonist with action on bacterial cell wall synthesis and modulation of NMDA receptors and is used for treating tuberculosis and studying neuropsychiatric disorders.

Ticarcillin disodium salt is a beta-lactam antibiotic that has in vitro activity against Gram-positive and Gram-negative bacteria. Ticarcillin is active against penicillinase-producing strains of Staphylococcus aureus, Enterobacter aerogenes, Proteus mirabilis, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Serratia marcescens, Streptococcus pyogenes, Streptococcus faecalis, and Streptococcus pneumoniae. Furthermore, it inhibits transpeptidase activity of the cell wall of bacteria which prevents peptidoglycan synthesis. It is bactericidal for many bacteria at low concentrations.

Purfalcamine is a synthetic pharmaceutical compound that belongs to a class of molecules known as small-molecule inhibitors. It is sourced through advanced chemical synthesis, enabling precise structural modifications to optimize its biological activity. The mode of action of Purfalcamine involves selective inhibition of a specific target protein involved in key cellular signaling pathways. This targeted interaction disrupts abnormal cellular processes, making it a promising therapeutic candidate for certain diseases.

Aminosidine is a nucleoside analogue that inhibits the HIV-1 reverse transcriptase and the integrase, which are enzymes involved in viral DNA synthesis. Aminosidine is active against Leishmania spp., but not against bacteria. Aminosidine has been shown to be effective in experimental models of human bowel disease and in patients with inflammatory bowel disease. It was also found to be active against wild-type strains of human immunodeficiency virus type 1, but not resistant mutants. The mechanism of action is the inhibition of cellular mitochondrial membrane potential.

Ganciclovir is an antiviral agent specifically designed for culture media use. It is a synthetic analogue of 2'-deoxy-guanosine, derived from nucleoside compounds, and operates primarily by inhibiting the replication of viral DNA. Its mode of action involves selective phosphorylation by viral kinases, which converts it into ganciclovir triphosphate, a potent inhibitor of viral DNA polymerase, ultimately preventing viral DNA synthesis.

Tromantadine hydrochloride is a synthetic antiviral compound, which is a derivative of adamantane. It originates from chemical synthesis, tailored specifically to target viral processes. Tromantadine hydrochloride primarily exerts its effects by inhibiting the penetration of virus particles into host cells and impeding the subsequent stages of viral replication. This mode of action effectively reduces the viral load and hinders the progression of the infection.

Desmethyl ferroquine is an antimalarial compound, which is a derivative of ferroquine. It is synthesized through chemical modification processes, specifically designed to enhance its pharmacokinetic and pharmacodynamic properties. This compound exhibits its mode of action by compromising the integrity of the Plasmodium parasite's digestive vacuole. By doing so, it disrupts heme detoxification, which is crucial for the parasite’s survival within red blood cells.

Please enquire for more information about Cephalexin hydrate, Antibiotic for Culture Media Use Only including the price, delivery time and more detailed product information at the technical inquiry form on this page

8-Fluoro erythromycin is a synthetic derivative of the macrolide antibiotic erythromycin. It is derived from the fermentation of *Streptomyces erythraeus*, a species known for producing erythromycin, which is chemically modified to include a fluorine atom at the eighth position. This modification enhances its pharmacokinetic properties, improving its stability and bioavailability compared to the parent compound.

Abacavir sulfate is a pharmaceutical compound classified as a nucleoside reverse transcriptase inhibitor (NRTI), which is derived from synthetic sources. Its mode of action involves the inhibition of the reverse transcriptase enzyme, essential for the replication of HIV. By incorporating itself into the viral DNA chain during replication, Abacavir effectively halts the process, preventing further multiplication of the virus within the host cells.

This antiretroviral medication is primarily used in the management and treatment of human immunodeficiency virus (HIV-1) infections. Abacavir sulfate is a critical component in highly active antiretroviral therapy (HAART), contributing to the reduction of viral load, enhancing immune function, and improving the long-term clinical outcomes in patients living with HIV. Its application in combination therapies has been instrumental in transforming HIV from a fatal disease into a manageable chronic condition.

Nigericin transports cations across the membrane of the cell and it is used to study anion transport. It can be used as a buffer to control pH value inside of the cell.

Cefquinome is a broad-spectrum antibiotic, which is a fourth-generation cephalosporin. It is derived from the β-lactam class of antibiotics and is specifically designed for veterinary applications. Its mode of action involves the inhibition of bacterial cell wall synthesis, leading to cell lysis and death. This action is facilitated through the binding of cefquinome to penicillin-binding proteins, which undermines the structural integrity of bacterial cell walls, proving effective against both Gram-positive and Gram-negative bacteria.

(E)-10,11-Didehydro-11-deoxy-6-O-methylerythromycin is a semisynthetic macrolide antibiotic, which is derived from erythromycin, a natural product obtained from the bacterium *Saccharopolyspora erythraea*. This compound functions as an inhibitor of protein synthesis by binding to the 50S ribosomal subunit of bacteria, thus preventing the growth and proliferation of susceptible bacterial strains. The alteration in its chemical structure, notably the methylation at the 6-O position, enhances its stability and improves its pharmacokinetic profile compared to the parent compound, erythromycin.

Perfluorodecanephosphonic acid is a fluorinated organic compound, which is synthesized through the controlled polymerization of fluorinated precursors. It is characterized by its unique perfluorinated alkyl chain and a phosphonic acid group, providing a distinctive combination of hydrophobic and functional properties. Its mode of action involves the strong adsorption onto surfaces through the phosphonic acid moiety, allowing the formation of highly stable self-assembled monolayers (SAMs).

Telavancin is a lipoglycopeptide antibiotic, which is a semi-synthetic derivative of vancomycin. Its source is derived through modifications of the glycopeptide antibiotic, specifically aimed to enhance antibacterial activity. Telavancin functions by inhibiting cell wall synthesis in Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It does this by binding to the D-alanyl-D-alanine terminus of cell wall precursors, disrupting peptidoglycan polymerization and, consequently, cell wall integrity. Additionally, Telavancin increases membrane permeability and disrupts membrane potential, further enhancing its bactericidal activity.

Tigecycline mesylate is a novel glycylcycline antibiotic, which is a derivative of the tetracycline class of antibiotics. It is a semi-synthetic product derived from minocycline, exhibiting a broad spectrum of antibacterial activity. Tigecycline mesylate functions through the inhibition of bacterial protein synthesis. It achieves this by binding to the 30S ribosomal subunit, thereby preventing the incorporation of amino acid residues into elongating peptide chains, a crucial step in protein production.

Dicloxacillin is a penicillin antibiotic that is used to treat bacterial infections of the gastrointestinal tract, skin, and urinary tract. It binds to the penicillin-binding proteins in bacterial cell walls by competitive inhibition. Dicloxacillin inhibits bacterial growth by binding to the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. Dicloxacillin sodium salt is available as tablets for oral administration or as an intravenous solution for injection. It can interact with other drugs, such as benzalkonium chloride and matrix effect; it also has analytical methods such as chromatographic analysis and rate constant.

Tenofovir alafenamide (free base) is a prodrug of tenofovir with action on viral reverse transcriptase to block replication and is used for treating HIV/AIDS and chronic hepatitis B with improved safety profile.